- Home
- MAGH vs HRTX Comparison
MAGH vs HRTX Comparison
Compare MAGH & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$6.85
HOLD
Current Price
$1.37
Company Overview
Basic Information| Metric | MAGH | HRTX |
|---|---|---|
| Founded | 2012 | 1983 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 225.4M | 203.5M |
| IPO Year | 2025 | 1987 |
Fundamental Metrics
Financial Performance| Metric | MAGH | HRTX |
|---|---|---|
| Price | $6.85 | $1.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 1.2M | ★ 2.1M |
| Earning Date | 12-23-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | $11,752,129.00 | ★ $155,097,000.00 |
| Revenue This Year | N/A | $8.98 |
| Revenue Next Year | N/A | $11.57 |
| P/E Ratio | $7,194.11 | ★ N/A |
| Revenue Growth | N/A | ★ 12.60 |
| 52 Week Low | $0.99 | $1.00 |
| 52 Week High | $6.94 | $2.68 |
Technical Indicators
Market Signals| Indicator | MAGH | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 69.56 |
| Support Level | N/A | $1.10 |
| Resistance Level | N/A | $1.37 |
| Average True Range (ATR) | 0.00 | 0.07 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 91.43 |
Price Performance
Historical Comparison MAGH
HRTX
About MAGH Magnitude International Ltd Ordinary Shares
Magnitude International Ltd is providing electrical installation services to customers in both the private and public sectors in Singapore. It includes the planning, design, material selection, installation, testing, commissioning and certification of the electrical equipment/systems to be installed. The Group's revenue is derived from Singapore.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.